Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid for prevention of rectal complications during prostate radiotherapy
IRCT20241210064017N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hyaluronic acid in prostate cancer (PCa) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Rectal complication grade and Time interval to complication onset. Started Aug 2022; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on IRCT20241210064017N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241210064017N1.